Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004134 (
ataxia
)
15,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Spino-Cerebellar-
Ataxia
type 38 (SCA38) is caused by missense mutations in the very long chain
fatty acid elongase
5 gene,
ELOVL5
. The main clinical findings in this disease are
ataxia
, hyposmia and cerebellar atrophy. Mice in which
Elovl5
has been knocked out represent a model of the loss of function hypothesis of SCA38. In agreement with this hypothesis,
Elovl5
knock out mice reproduced the main symptoms of patients, motor deficits at the beam balance test and hyposmia. The cerebellar cortex of
Elovl5
knock out mice showed a reduction of thickness of the molecular layer, already detectable at 6 months of age, confirmed at 12 and 18 months. The total perimeter length of the Purkinje cell (PC) layer was also reduced in
Elovl5
knock out mice. Since Elovl5 transcripts are expressed by PCs, whose dendrites are a major component of the molecular layer, we hypothesized that an alteration of their dendrites might be responsible for the reduced thickness of this layer. Reconstruction of the dendritic tree of biocytin-filled PCs, followed by Sholl analysis, showed that the distribution of distal dendrites was significantly reduced in Elovl5 knock out mice. Dendritic spine density was conserved. These results suggest that
Elovl5
knock out mice recapitulate SCA38 symptoms and that their cerebellar atrophy is due, at least in part, to a reduced extension of PC dendritic arborization.
...
PMID:Motor Deficits and Cerebellar Atrophy in
Elovl5
Knock Out Mice. 2916 54